A stem cell transplant is a procedure that can treat or cure a number of conditions: bone marrow diseases, inherited immune disorders, hemoglobinopathies and some types of cancer. Dr. Gizelle Popradi, hematologist and director of the Stem Cell Transplant Program of the McGill University Health Centre tells us more about this life-saving therapy and its use in the treatment of cancer patients.
Une greffe de cellules souches est une intervention qui peut traiter ou guérir diverses maladies : des maladies de la moelle osseuse, des hémoglobinopathies (anomalies des globules rouges) et des troubles immunitaires congénitaux, de même que certains types de cancer, tels que les leucémies, les lymphomes et les myélomes. La Dre Gizelle Popradi, hématologiste et directrice du programme de greffe de cellules souches du Centre universitaire de santé McGill (CUSM), nous en dit un peu plus sur ce traitement salvateur et sur son usage pour soigner les patients atteints d’un cancer.
Dr. Jeff Wiseman, an Internal Medicine physician at the Royal Victoria Hospital of the McGill University Health Centre is currently developing a serious medical smartphone-based game called The Deteriorating Patient with the aim of helping medical students learn how to stabilize severely ill patients when on call.
Le Dr Jeff Wiseman, interniste à l’Hôpital Royal Victoria du Centre universitaire de santé McGill est à préparer un jeu médical sérieux pour téléphone intelligent, appelé Deteriorating Patient, afin de contribuer à l’apprentissage des étudiants en médecine qui doivent apprendre à stabiliser des patients gravement malades lorsqu’ils sont sur appel.
In advance of his lecture at the upcoming conference, Canada on the Global Stage, hosted by the McGill Institute for the Study of Canada on Feb. 11-12, former diplomat Colin Robertson spoke to the Reporter about Canada’s place in the world, the primary challenges the country must tackle in the next five years, and the changing face of the diplomatic corps.
On this, World AIDS Day (Dec. 1), the Reporter spoke to Dr. Marina Klein about her research on patients with HIV and chronic hepatitis – a particularly virulent combination that effects more than 20,000 Canadians and millions more worldwide. According to Dr. Klein, the key to treating these patients lies just as much in education and social programs as it does in antiretroviral pharmaceuticals.
This year marks the 50th anniversary of the pioneering research by Drs. Phil Gold and Samuel Freedman, who, together, discovered and defined the Carcinoembryonic Antigen, the most frequently used blood test used as a biomarker in the diagnosis and management of patients with cancer. Dr. Gold spoke to the Reporter about the past, present and future of cancer research.
In advance of his Nov. 4 Osler lecture, Dr. E. Fuller Torrey sat down with the Reporter to discuss schizophrenia, modern psychiatry and patient advocacy.
McGill History prof., Gil Troy, talks about the kinds of challenges writers like the Cundill Prize finalists face, his own existential fears as an author and his new book, The Age of Clinton.
Francois Miller arrived at McGill this past spring as Manager of the Office of Sustainability. Recently, Miller sat down with the Reporter to talk about his mandate, the Sustainability Projects Fund (SPF), Vision 2020 and his plans to further grow the culture of sustainability at McGill.